The genetic knockout of C9orf50 induces an intrinsic innate immune response in cancer cells by disrupting splicing, thereby transforming immunologically cold tumors into inflamed phenotypes characterized by increased T cell infiltration and enhanced antitumor activity. Here, C9orf50 is linked to cancer.